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ABSTRACT
Schnurri-3 (Shn3) is an essential regulator of postnatal skeletal remodeling. Shn3-deﬁcient mice (Shn3–/–) have high bone mass;
however, their bone mechanical and material properties have not been investigated to date. We performed three-point bending
of femora, compression tests of L3 vertebrae. We also measured intrinsic material properties, including bone mineralization density
distribution (BMDD) and osteocyte lacunae section (OLS) characteristics by quantitative backscatter electron imaging, as well as col-
lagen cross-linking by Fourier transform infrared microspectroscopy of femora from Shn3–/– and WT mice at different ages
(6 weeks, 4 months, and 18 months). Moreover, computer modeling was performed for the interpretation of the BMDD outcomes.
Femora and L3 vertebrae from Shn3–/– aged 6 weeks revealed increased ultimate force (2.2- and 3.2-fold, p < .01, respectively).
Mineralized bone volume at the distal femoral metaphysis was about twofold (at 6 weeks) to eightfold (at 4 and 18 months of
age) in Shn3–/– (p < .001). Compared with WT, the average degree of trabecular bone mineralization was similar at 6 weeks, but
increased at 4 and 18 months of age (+12.6% and +7.7%, p < .01, respectively) in Shn3–/–. The analysis of OLS characteristics
revealed a higher OLS area for Shn3–/– versus WT at all ages (+16%, +23%, +21%, respectively, p < .01). The collagen cross-link ratio
was similar between groups. We conclude that femora and vertebrae from Shn3–/– had higher ultimate force in mechanical testing.
Computer modeling demonstrated that in cases of highly increased bone volume, the average degree of bone matrix mineraliza-
tion can be higher than in WT bone, which was actually measured in the older Shn3–/– groups. The area of 2D osteocyte lacunae
sections was also increased in Shn3-deﬁciency, which could only partly be explained by larger remnant areas of primary
cortical bone. © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and
Mineral Research © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and
Mineral Research.
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Introduction
Schnurri-3 (Shn3), a member of the ZAS family of zinc ﬁngerproteins, has been identiﬁed as a potent and essential regu-
lator of postnatal skeletal remodeling.(1,2) Studies in mice indi-
cate that Shn3 regulates osteoblastic bone formation via ERK
(extracellular-signal regulated kinases) downstream of Wnt sig-
naling.(3) Further mouse studies suggested that Shn3 might
inhibit osteoblast activity directly through Runx-2, and might
control osteoclastic bone resorption indirectly.(2,4,5) Previous
in vitro experiments provided evidence that Shn3–/– calvarial
osteoblast’s mRNA expression was different from controls; levels
of bone sialoprotein and osteocalcin were elevated, whereas
levels of alkaline phosphatase mRNA were similar to controls.(5)
Recently, signiﬁcant increases in Shn3 mRNA expression in the
presence of proinﬂammatory cytokines were shown, suggesting
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a signal for osteoclast activation in the studied human ﬁbroblast-
like cells.(6)
Shn3-null mice are born healthy, yet show markedly aug-
mented osteoblastic bone formation,(2) as well as a reduction in
osteoclastic bone resorption,(4) resulting in a high bone mass
phenotype. These mice continue to accrue bone with age and
are therefore protected from age-related bone loss,(4) as well as
loss caused by disuse resulting from muscle paralysis induced
via Botox-induced transient paralysis of calf muscles.(4) More-
over, inducible knockdown of SHN3 enhances bone mass in
adult mice.(3) These results in mice suggest that the inhibition
of Shn3 expression or activity might be a promising target for
the development of antiosteoporotic drugs.(3)
Previous studies have shown that in addition to bone mass/-
volume, several other factors, including bone architecture and
inherent bone material properties such as bone mineral and
matrix tissue characteristics, play a pivotal role in the overall
mechanical competence of bone.(7,8) Currently, osteoporosis
treatments such as antiresorptives (eg, bisphosphonates) or ana-
bolic agents (eg, parathyroid hormone) lead to an increase in
bone mass as measured by X-ray absorptiometry; however,
they differ signiﬁcantly in their effect on bone material
properties.(9–12) Thus, information about the mechanical perfor-
mance and the intrinsic bone material properties in the absence
of Shn3 is important to obtain so as to accommodate the poten-
tial development of an antiosteoporotic intervention based on
the inhibition of Shn3.
In the present work, we studied bones from Shn3–/– and WT
mice at different ages. Overall mechanical performance was
measured using typical biomechanical tests including three-
point bending of femora(13) and compression tests of verte-
brae.(14) We also investigated bone material properties focusing
on the bone matrix mineralization. Mineralization of newly
formed healthy bone is a multistep process involving many fac-
tors, such as mineral-binding extracellular matrix proteins and
proteoglycans, mineralization-inhibiting proteins, and matrix
vesicles.(15,16) In view of previous results from in vitro studies pre-
viously discussed, it is important to have information on themin-
eralization of the bone formed under Shn3 deﬁciency. We used
quantitative backscatter electron imaging (qBEI)(8) to character-
ize the bone mineralization density distribution (BMDD) and
osteocyte lacunae section (OLS) characteristics in long bones.
Finally, Fourier transform infrared imaging (FTIRI)(17) was per-
formed to gain information on enzymatic collagen cross-links
in trabecular bone.
Materials and Methods
Samples and sample preparation
The generation of Shn3-deﬁcient mice with a C57BL/6 back-
ground followed the institutional guidelines for the care, hus-
bandry conditions, and use of animals (described in detail
elsewhere).(2) For biomechanical tests, L3 vertebrae (n = 6 from
Shn3–/– and n = 7 from WT) and femurs (n = 6 from Shn3–/–
and n = 7 from WT) from 6-week-old animals were harvested
and stored at –80C before testing.
For bonematerial analysis, undecalciﬁed femora from 6-week-
old, 4-month-old, and 18-month-old male and female WT and
Shn3–/– mice were retrieved, ﬁxed in alcohol, and embedded
in polymethylmethacrylate (PMMA). Three- to four-micron-thin
longitudinal sections were cut from the samples block for FTIRI
analysis. The remaining block was prepared for qBEI by grinding
and polishing, and the surface carbon coated as previously
described.(8,18)
Bone biomechanics
The volumetric bone mineral density (vBMD) and the cross-
sectional area of vertebrae and femora from mice aged 6 weeks
were measured using pQCT (XCT Research M+ pQCT machine;
Stratec Medizintechnik, Pforzheim, Germany). For this purpose,
femora and L3 vertebrae were obtained and stored in 70% etha-
nol after necropsy. In the femur, one slice (0.2-mm-thick) in the
middiaphysis and three slices in the distal femoral metaphysis
located 1.5, 2.0, and 2.5 mm from the articular surface of the
knee joint were measured. In the L3 vertebrae, three slices were
measured, one in a midtransversal plane and two located
0.5 mm rostral and caudal of the midtransversal plane. The
vBMD of the femoral metaphysis and that of the vertebra repre-
sents the mean for these slices. Voxel size was 70 μm for all mea-
surements. A threshold of 450mg/cm-3 was used for detection of
trabecular bone, and thresholds of 500mg/cm-3 and 600mg/cm-
3 were used for measurement of cortical bone in L3 vertebrae
and femora, respectively.(14)
Femora and vertebrae from mice aged 6 weeks were loaded
to failure as described in detail elsewhere.(14) A Zwick Z020/
TN2A material testing machine (Zwick GmbH & Co KG, Ulm,
Germany) utilizing a 1-kN-force detector with a force resolution
of 0.01 N(14) was used. Brieﬂy, three-point bending tests of the
femurs were performed under hydrated bone matrix condi-
tions. The distance between the lower supports for the bend-
ing tests was 5 mm. In the compression tests, planoparallel
vertebral body cylinders of 2.0-mm height were loaded to
failure.
Geometric characteristics of the vertebrae and femora were
included in the calculation of the apparent strength. For the lat-
ter, the ultimate force of the L3 under compression was normal-
ized to the cross-sectional area of the L3, whereas the ultimate
force under bending was normalized to the areal moment of
inertia as described below. We use the term “apparent strength”
(σ) as this calculated measure does not consider the void volume
within the bone tissue, which is particularly high in the vertebral
body. Thus for the vertebra, the apparent strength was calcu-
lated as a ratio between the ultimate force Fmax and the total
cross-sectional bone tissue area, CsAr, ie,
σ = Fmax=CsAr ð1Þ
For the estimation of the apparent strength of the femora, the
cross-sectional cortical area (Ct.Ar) and the cortical thickness
(Ct.Th) obtained from the pQCT were used to calculate the outer
(Router) and inner radius (Rinner), assuming that the cross-section








Rinner = Router −Ct:Th: ð3Þ
Based on the information regarding Router and Rinner, the areal
moment of inertia (I), a measure for the bone’s resistance to
bending, can be formulated:








and an estimation of the strength σ can be calculated using the





where Fmax L4 is the bending moment (with Fmax being the ultimate
force and L the distance between the lower supports) and c the
distance from the neutral axis to the point of loading (ie, Router
in this case).
Quantitative backscattered electron imaging (qBEI)
qBEI is based on the backscatter electron signal from an approx-
imately 1.5-μm- thick bone surface layer. This signal is principally
dependent on the average atomic number in the target material
and thus related to calcium content in bone (details described
previously(18)). A scanning electron microscope (DSM 962; Zeiss,
Oberkochen, Germany) equipped with a four-quadrant semicon-
ductor backscattered electron BE detector was used. The
BE-signal (gray scale) was calibrated using the “atomic number
contrast” between carbon (C; Z = 6) and aluminum (Al; Z = 13)
as reference materials. Consequently, one gray-level step corre-
sponds to 0.17 wt% Ca. The calibrated digital images were used
for a 2D estimation of microstructure of mineralized (md) bone
(mdBV/TV; mineralized bone volume per tissue volume), mdTb.
Th (mineralized trabecular thickness), mdTb.N (mineralized tra-
becular number), and for the BMDD.
Evaluation of mdBV/TV for the metaphyseal region was per-
formed using a custom-made automated image analysis routine
(NIH Image 1.52, W. Rasband, National Institutes of Health,
Bethesda, MD, USA) of qBEI images (Fig. 1A-F) by discriminating
between gray levels of mineralized and not mineralized tissue or
embedding material as described elsewhere.(19) Measurements
of mdBV/TV were performed at a distance of 500 to 1500 μm
from the growth plate in the sagittal sections (region of interest
for this analysis is indicated by the dashed line in Fig. 1A).
BMDD measurements were performed in cancellous bone at
the metaphyseal region, as well as in cortical bone in the mid-
shaft region. For cancellous BMDD, bone was measured within
the metaphysis in each sample (the area of 500 μm adjacent to
the growth plate was excluded). Cortical BMDD was obtained
from regions as shown in Fig. 1, in the midshaft of both cortices.
Calibrated digital BE-images with a 200× (resolution 1 μm/pixel)
nominal magniﬁcation were acquired, from which gray-level his-
tograms (frequency distributions) were derived indicating the
percentage of mineralized bone area (corresponding to the
number of pixels) with a certain gray level. The following BMDD
parameters were calculated (see plotted in the BMDD-example
in Fig. 2A): CaMean, corresponding to the weighted average Ca
concentration of the mineralized bone area; CaPeak, which is
the most frequently observed Ca concentration; CaWidth, char-
acterized as the width at half-maximum of the BMDD histogram
peak indicating the heterogeneity of mineralization caused by
the coexistence of bone areas of different ages and thus of differ-
ent degrees of mineralization; and CaLow, representing the
amount of tissue area mineralized below 17.68 wt% Ca, which
is the mineral content achieved in newly formed lamellar human
bone during the primary mineralization process.(20)
Additionally, the calibrated qBEI images were also analyzed
for 2D-information about the osteocyte lacunae sections (OLS)
characteristics in the cortical bone area.(21) For this purpose, qBEI
images were transformed to binary images using a threshold
based on a ﬁxed gray level (corresponding to 5.2 wt% Ca). The
OLS were extracted using a minimum andmaximum size thresh-
old of 5 μm2 and 80 μm2, and analyzed based on a custom-made
macro in ImageJ software (version 1.50f; NIH, Bethesda, MD,
















OLS−perimeter μmð Þ=meanOLSperimeter per sample
The viability of the cells within the OLS cannot be evaluated
by this method.
Computer modeling of the average mineral content
(CaMean)
As previously described,(23) a mathematical model was applied
to the metaphyseal trabecular bone of Shn3–/–mice to simulate
the time evolution of the BMDD and CaMean.(23) The model
assumes the mineralization kinetics to be independent of age
and genotype. In contrast to previous applications of this model,
the trabecular BV/TV was not set constant, but was allowed to
increase rapidly with time. The rates of bone deposition and
bone resorption were chosen to agree with the measured BV/TV.
Fourier transform infrared imaging (FTIRI)
FTIRI was used to determine the collagen pyridinoline (pyr)/diva-
lent enzymatic cross-link ratio (pyr – trivalent/divalent ratio) in
metaphyseal cancellous bone tissue of mice aged either 6 weeks
or 4 months. All spectroscopic analyses were performed in trans-
mission, on 4-μm-thick bone sections, using a Bruker Equinox
55 spectrometer coupled to a mercury cadmium telluride
(MCT) focal plane array detector (64 × 64 array) imaged onto
the focal plane of an IR microscope (Bruker Hyperion 3000; Bru-
ker Optics, Vienna, Austria). Spectral resolution of 4 cm−1 and
spatial resolution of approximately 6.3 × 6.3 μm2 were used.
The instrument was equipped with a 15× objective lens and a
motorized stage (1 μm). FTIRI spectral images (n = 3 per sam-
ple, each covering an area of 300× 300 μm2 andmeasured once)
were collected in trabecular bone areas and the mean pyr/diva-
lent collagen cross-link ratios were evaluated. For that, the spec-
tral regions were baseline corrected, and water vapor and
polymethylmethacrylate (PMMA) were spectrally subtracted(24)
using Grams 32 (Salem, MA, USA) software. Along with baseline
correction, the spectral analysis of the amide I band was per-
formed to isolate underlying peaks (approximately 1660 and
1690 cm−1), corresponding to two of the major type I bone colla-
gen cross-links, namely pyr and divalent ones to calculate the
ratio of pyr/divalent.(24)
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Statistical analysis
All measurements were performed with the investigator blinded
to the animal groups. Biomechanical data, cross-sectional areas,
and BMDs which were obtained from animals of one speciﬁc
agewere compared using unpaired t tests or Mann-Whitney rank
sum tests (if data were not normally distributed). The statistical
comparison for histomorphometric structural parameters, BMDD
data, OLS-characteristics, and collagen cross-link ratios (which
were all obtained from mice of different ages) was based on
two-way ANOVA tests (factors genotype and age) with Tukey
post hoc comparisons. Statistical analyses were done using Sig-
maStat 4.0 software (Systat Software, San Jose, CA, USA). The
conﬁdence level was set at 95%.
Fig. 1. Backscatter electron (BE) overview images of typical examples of longitudinal sections of distal femora from 6-week-old (A, B), 4 month old (C, D),
and 18-month-old (E, F) WT and Shn3 null mice (WT in A, C, E; Shn3–/– in B, D, F). Generally, the images show the tremendous increase in cancellous and
cortical bone volumewith age in the Shn3-deﬁcient mice. The region indicated by the dashed line in the overview image in Fig. 1A indicates the region of
interest for the analysis of the microstructure of the mineralized bone, and the bar represents 1 mm. Detail images of cancellous and cortical bone
obtained at higher magniﬁcation are also shown (the asterisks in the overview images show the area of the detail images). The bar in the detail image
indicates 100 μm. In the detail image of the Shn3–/– mouse aged 18 months (F), the dashed white line indicates the boundary of the remnant area of
primary cortical bone (top) from the lamellar cortical bone (bottom). Such two distinct areas can be seen in cortical bone detail images for all Shn3–/–
and for the youngest WT. Osteocyte lacunae section morphology is clearly different in primary compared with lamellar cortical bone.
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RESULTS
Mechanical competence of whole bone
Shn3–/–mice had signiﬁcantly greater bone ultimate force (Fmax)
at both the appendicular and axial skeleton compared with WT
mice (Table 1). Fmax of femurs in three-point bending was
2.2-fold (p < .001) and L3 vertebral bodies in compression tests
was 3.2-fold (p < .01) increased. This increase in mechanical
competence was associated with a signiﬁcant increase in the
cortical cross-sectional area of the femur at midshaft (+50%)
and with an increase of cross-sectional area of the vertebrae
(+30%, both p = .001) as measured by pQCT before mechanical
testing. Considering the contribution of the bone geometry to
the measured ultimate force the resulting apparent strength
[Equations (1), (5)] was still signiﬁcantly higher in both, bending
(p = .01) and compression (p = .003) for Shn3–/– compared
with WT bone. Additionally, the volumetric bone density was
signiﬁcantly elevated for both skeletal sites (+21% for femur
and +30% for vertebra, both p < .001; data summarized in
Table 1).
Bone mineralization density distribution (BMDD)
Figure 1 shows typical overview qBEI images (one characteristic
image per study group) together with examples of detailed
images of cancellous and cortical bone for each sample of the
investigated longitudinal distal femoral bone. Figure 2 shows
the derived BMDD parameters (Fig. 2A) and typical BMDD curves
measured in Shn3–/– andWT animals (Fig. 2B). In Fig. 2B, the sim-
ilarity of the trabecular BMDDs from Shn3–/– and WT at 6 weeks
of age and the differences between the genotypes at 4 months
are demonstrated. In the full-grown animals, the BMDD of
Shn3–/– is shifted toward higher mineralization. Two-way
ANOVA followed by Tukey post hoc tests revealed an interaction
between the factors genotype and age for all trabecular BMDD
parameters, indicating that the age development of the trabecu-
lar BMDD is different in the two study groups, Shn3–/– and WT
(Table 2). Trabecular CaMean was not different at the age of
6 weeks, whereas it was signiﬁcantly increased at 4 and
18 months in Shn3–/– compared with WT (+12.6% and +7.7%,
respectively, both p < .001), see also Fig. 3A. At the age of
4 months and 18 months, trabecular CaLow was signiﬁcantly
reduced in Shn3–/– (by –69.2% and –49.4%, respectively, both
Table 1. pQCT and Biomechanical Data
Femur
WT (n = 7) Shn3–/– (n = 6) p Value
vBMD (mg/cm3) 531.5 (23.3) 644.1 (31.8) <.001
CsAr (mm2) 1.96 (0.06) 2.51 (0.12) <.001
Ct.Ar (mm2) 0.78 (0.76; 0.81) 1.17 (1.12; 1.38) .001
Ct.Th (mm) 0.18 (0.17; 0.19) 0.24 (0.23; 0.29) .001
Fmax (N) 8.26 (0.96) 18.18 (2.00) <.001




41.32 (4.46) 55.29 (10.86) .01
Vertebra L3
WT (n = 7) Shn3–/– (n = 6) p Value
vBMD
(mg/cm3)
419 (18.6) 543.3 (35.8) <.001
CsAr (mm2) 1.27 (1.24; 1.46) 1.61 (1.54; 1.67) .001
Ct.Th (mm) 0.32 (0.01) 0.54 (0.03) <.001




5.67 (3.47) 14.85 (5.96) .003
Data are mean (SD) or median (25th; 75th percentiles). n = number of
studied mice. p Values are based on t test or Mann-Whitney rank
sum test.
vBMD = volumetric bone mineral density; Ct.Ar = cortical area; Ct.Th =
cortical thickness; Fmax = ultimate force under bending or compression; I
= areal moment of inertia; apparent strength = ultimate force normalized
to I [(under bending, see Equation (5)] or CsAr [under compression, see
Equation (1)]; CsAr = total cross-sectional bone tissue area.
Fig. 2. (A) Example of a bone mineralization density distribution-
(BMDD-) curve showing the calculated BMDD parameters. CaMean =
weighted mean calcium concentration; CaPeak = most frequent calcium
concentration; CaWidth = full width at half maximum of the BMDD, an
index for the heterogeneity of mineralization; CaLow = percentage of
bone area having a calcium concentration below 17.68 wt% Ca, repre-
senting the percentage of low mineralized lamellar bone undergoing
the primary bone mineralization process. (B) Measured BMDD from WT
and Shn3–/– aged 6 weeks (top) or 4 months groups (bottom). Dotted
lines indicate WT, solid lines Shn3–/–.
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p < .001; Table 2). With increasing age, the Shn3–/– bone mate-
rial showed signiﬁcant changes in trabecular CaMean, CaPeak,
and CaLow (Table 2); these parameters revealed only minor
changes with age in the WT animals (Table 2).
For cortical BMDD parameters, the two-way ANOVA compari-
son did not reveal any signiﬁcant interaction between factors
genotype and age, except for CaWidth (Table 2, Fig. 3B). Post
hoc comparison indicated signiﬁcantly higher cortical CaWidth
in Shn3–/– compared with WT at the ages of 4 and 18 months
(+8.9%, p < .05 and +22%, p < .001, respectively; Table 2). The
changes in cortical BMDD with age showed an increase in
CaMean and CaPeak and a decrease in CaLow in both genotypes
(Table 2), whereas CaWidth remained constant in WT and
increased in Shn3–/–.
Relationship between changes in cancellous bone volume
and CaMean
The mineralized cancellous bone volume of the distal femoral
metaphysis was signiﬁcantly increased in Shn3–/– mice com-
pared with WT. The high bone mass phenotype in Shn3–/–
mice was associated with a distinct increase in thickness of
mineralized trabeculae as demonstrated in Figs. 1 and 3C.
Shn3–/– had a cancellous mdBV/TV of 43% in the youngest
age group, which increased up to 55% at 4 months (see
Table 3; an overview of this increase can be seen qualitatively
also in the images of the longitudinal sections from the mice
in Fig. 1). In contrast, WT exhibited mdBV/TV of only 18% at
the age of 6 weeks, which declined to 7% at 4 months. Com-
puter modeling of the BMDD(23) revealed that bone remodeling
with a positive net balance leads to an increased CaMean in the
long run (Fig. 4). The simulated time course of CaMean shows
that the considerable deposition of bone initially causes a
decrease of CaMean (at an animal age not considered in this
work). The continuation of bone deposition (increase in
mdBV/TV) leads to a marked increase in CaMean with age. This
time course is in line with the experimentally measured cancel-
lous CaMean values of the Shn3–/– (Fig. 4).
OLS characteristics
Two-way ANOVA comparison between the 2D-OLS characteris-
tics as obtained from the qBEI images in cortical bone of the fem-
oral midshaft revealed signiﬁcant differences for the factors age
and genotype (mean and SD, as well as p values for the factors
are given in Table 4). The interaction between these factors
was not signiﬁcant for all OLS parameters. Post hoc Tukey com-
parison of the separate study groups showed elevated OLS
porosity in Shn3-deﬁcient mice at the age of 6 weeks (+21%)
and 4 months (+33%; both p < .05), whereas OLS density was
Table 2. Bone Mineralization Density Distribution of Trabecular and Cortical Bone From the Femur
6 Weeks 4 Months 18 Months
Two-way
ANOVA (p values)







CaMean 22.30 22.63 22.41 25.24 a,d 23.10 24.88 a,d .004 <.001 <.001
(wt% Ca) (0.59) (1.16) (0.53) (0.60) (1.45) (0.73)
CaPeak 23.40 23.18 24.52 25.79 c,d 24.33 25.84 b,d .019 .003 <.001
(wt% Ca) (0.61) (1.27) (0.59) (0.77) (1.03) (0.71)
CaWidth 3.12 3.25 3.76 e 3.29 c 3.49 3.57 .035 .395 .005
(Δwt%Ca) (0.13) (0.43) (0.53) (0.16) (0.25) (0.21)
CaLow 9.38 8.81 11.43 3.52 a,d 7.98 h 4.04 a,d <.001 <.001 <.001
(% B.Ar) (1.62) (2.69) (2.23) (0.35) (3.15) (1.13)
Cortical
Bone
CaMean 23.94 23.99 25.55 e 25.88 d 26.27 d 27.08 d,h .420 .121 <.001
(wt% Ca) (1.04) (1.14) (0.69) (0.75) (0.43) (0.55)
CaPeak 24.87 24.57 26.23 e 26.51 d 26.82 d 27.49 d .215 .359 <.001
(wt% Ca) (0.86) (1.08) (0.77) (0.75) (0.43) (0.59)
CaWidth 3.01 3.01 2.92 3.18 c 3.03 3.70 a,d,g <.001 <.001 <.001
(Δwt%Ca) (0.16) (0.13) (0.53) (0.14) (0.13) (0.38)
CaLow 4.19 3.69 2.54 f 2.31 f 1.76 d 1.51 d .814 .430 <.001
(% B.Ar) (1.92) (1.07) (2.23) (0.33) (0.44) (0.42)
Data show mean (SD). n = number of studied animals. In bold: data that are signiﬁcantly different to WT at similar age. Signiﬁcance by Tukey post hoc
comparison following two-way ANOVA is indicated by superscript letters.
CaMean = weighted mean calcium concentration; CaPeak = most frequent calcium concentration; CaWidth = full width at half maximum of the bone
mineralization density distribution, an index for the heterogeneity of mineralization; CaLow = percentage of bone area having a calcium concentration




cp < .05 versus WT.
dp < .001.
ep < .01.
fp < .05 versus 6 weeks.
gp < .001.
hp < .05 versus 4 months (all based on Tukey post hoc comparison).
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not signiﬁcantly different between the groups. The OLS area was
higher in Shn3-deﬁcient mice at all ages studied (+16% at
6 weeks, p = .001; +23% at 4 months, p < .01; and +21%
at 18 months, p < .01). OLS perimeter was increased in Shn3–/–
at the age of 4 months (+7.7%) and 18 months (+8.0%;
both p < .01).
Collagen cross-links ratio (pyr/divalent)
FTIRI analyses were performed on metaphyseal cancellous bone
of mice at 6 weeks and 4 months of age. Two-way ANOVA
revealed no signiﬁcant dependency of the collagen pyr/divalent
cross-link ratio on either age or genotype (Table 5).
Discussion
In this study, the mechanical competence of whole bone and
intrinsic bonematerial properties of Shn3–/–mice were assessed
and compared with those of WT mice. We found the ultimate
force under bending and compression signiﬁcantly increased
for femora and vertebrae, respectively. The increase in ultimate
force under compression of vertebra and bending of femora is
consistent with the increased vertebral cross-sectional bone
areas, as well as bone volume per tissue volume and the
increased cortical area and thickness, respectively, observed for
the Shn3–/–mice. However, the remarkable increase in mechan-
ical performance also suggests that the excessively formed bone
Fig. 3. Average degree of mineralization density (CaMean) and the percentage of low mineralized bone areas (CaLow) in (A) cancellous and (B) cortical
bone of the distal femur. (C) Microstructure of mineralized bone (mdBV/TV = mineralized bone volume per tissue volume andmdTb.Th = mineralized tra-
becular thickness) for WT and Shn3–/– mice at different ages. Data are mean (SD), WT in white, and Shn3–/– in gray. n = 8 animals per genotype at age
6 weeks, n = 6 at 4months and n = 8 at 18months. p < .001 based on Tukey post hoc test following two-way ANOVA. Only signiﬁcant differences between
Shn3–/– and WT of same age are shown. For all signiﬁcant differences see Table 2.
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material in these mice is not of compromised quality. This is in
clear contrast to previous studies on sodium ﬂuoride treatment
in osteoporotic patients where the strong anabolic effect led in
fact to a strong increase in vertebral bone mass, but not in a
reduction of vertebral fractures.(25,26) Bone material formed dur-
ing sodium ﬂuoride treatment revealed a disturbed and highly
heterogeneous mineralization distribution of the bone matrix
with partly increased and partly deﬁcient mineralization.(27) In
the present study, the improved mechanical performance
remained after normalization for the change in estimated geom-
etry (evidenced by the higher apparent strength).
The change in the volume of mineralized bone in the distal
femoral metaphyseal region with age was highly dependent on
the genotype. It is interesting that in the Shn3–/–mice the bone
volume is increasing, especially from 6 weeks to 4 months,
whereas the C57BL/6WTmice lose bonemass with age, in agree-
ment with the results of Glatt and colleagues.(28) Previous histo-
morphometric outcomes revealed a ﬁvefold increase in bone
formation rate based on both increased mineralizing surface
and mineral apposition rate in Shn3–/– mice, concurrently with
unaltered osteoblast surface. The number of osteoclasts was
comparable in Shn3–/– and WT skeletal tissue by histomorpho-
metric analysis,(2) although another publication reported that
the serummarkers of bone resorption were signiﬁcantly reduced
in young (6-week-old) Shn3–/– animals compared with WT
littermates,(4) further explaining the apparent positive net bal-
ance between bone formation and resorption. The ongoing
overproduction by the osteoblasts and decreased resorption by
the osteoclasts led to an osteosclerotic/osteopetrotic phenotype
in the older Shn3–/– mice. The 18-month-old Shn3–/– animals
exhibited a nearly ﬁlled-up marrow space and a considerably
increased cortical width compared with WT.
BMDD outcomes showed a normal degree ofmineralization in
the youngest study group, but a higher degree of bone matrix
mineralization in the full-grown Shn3-deﬁcient mice compared
with WT animals. Based on the established computer modeling
of the BMDD,(23) we would expect a lower degree of mineraliza-
tion in Shn3/-. As previously shown by experimental data and
computer modeling,(8,23) two processes are essential in the
determination of BMDD: (1) the mineralization kinetics, ie, the
time course of mineral accumulation in newly formed osteoid
deposited by the osteoblast, which starts with an initial rapid
phase of primary mineralization up to about 70% of ﬁnal mineral
content within days, followed by the slower phase of secondary
mineralization achieving full mineralization within
months(9,29–31); and (2) the bone turnover rate that determines
the fraction of bone volume, which is apposed and/or replaced
by new bone in a certain time (eg, year) because of bone (re)
modeling.(8) Based on the latter, a higher modeling/remodeling
rate will reduce both tissue age and CaMean and vice versa.(8)
This is valid for the case of balanced bone formation and resorp-
tion (ie, constant bone volume). However, in the present work,
the Shn3–/– exhibited a large increase in bone volume, thus
the computer model needed to be modiﬁed. Unlike previous
applications, trabecular bone volume was not set constant, but
was allowed to increase rapidly with time in the present work.
This modiﬁed computer model showed that the average calcium
concentration of bone (CaMean) ﬁrst decreases and subse-
quently increases with increasing bone volume (ie, increasing
animal age). Unfortunately, the drop in CaMean occurs at an
age not included in the present study. At the available ages,
Table 3. Microstructure of Mineralized Trabecular Bone at the Metaphysis of the Femur
6 Weeks 4 Months 18 Months
Two-way ANOVA
(p values)
WT (n = 8 ) Shn3–/– (n = 8) WT (n = 6) Shn3–/– (n = 6) WT (n = 8) Shn3–/– (n = 8) Inter action geno type Age
mdBV/TV (% ) 18.33 43.41a 7.10 54.91 a,c 5.87 c 47.55 a .003 <.001 .301
(3.35) (8.58) (3.35) (10.97) (3.44) (14.37)
mdTb.Th. (μm) 38.69 51.04 34.73 126.1 a,b 51.60 105.3 a,b <.001 <.001 <.001
(4.48) (10.12) (7.47) (32.68) (27.37) (34.85)
mdTh.N (1/mm) 4.74 8.69 a 1.99 b 4.41 a,b 1.19 b 4.61 a,b .136 <.001 <.001
(0.68) (1.79) (0.61) (0.30) (0.61) (0.92)
Data aremean (SD). n = number of studiedmice. In bold: data that are signiﬁcantly different toWT at similar age (based on Tukey post hoc comparison).
Signiﬁcance by Tukey post hoc comparison following two-way ANOVA is indicated by superscript letters.
mdBV = mineralized bone volume per tissue volume; mdTb.Th. = mineralized trabecular thickness; mdTh.N = mineralized trabecular number.
ap < .001 versus WT.
bp < .001.
cp < .05 versus 6 weeks (all based on Tukey post hoc comparison).
Fig. 4. Simulation of time evolution of CaMean (weighted mean calcium
concentration), when the trabecular bone volume is increasing with ani-
mal age as observed in the Shn3–/–mice. Line: prediction from the com-
puter model; black solid circles: experimental data points. Error barSD.
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the computer model predicts the similarity of CaMean at
6 weeks and an increased CaMean at 4 and 18 months in line
with the experimentally measured BMDD. Our ﬁndings suggest
that in a case with large increases in bone volume (in Shn3–/–,
trabecular bone volume increase is about twofold at 6 weeks
and about eightfold in full-grown animals), the average degree
of mineralization can be similar or even higher compared with
WT bone, solely caused by the increase in bone volume. This
can be explained by the fact that the increase of bone volume
causes an overall higher average tissue age, enabling a longer
period of secondary mineralization. Interestingly, high bone vol-
ume accompanied by increased bone matrix mineralization was
also observed previously in mice overexpressing the transcrip-
tion factor Fra-1,(19) as well as in sclerostin-antibody-treated WT
mice.(32)
Using qBEI images, we also measured the characteristics of
the 2D sections of osteocyte lacunae in femoral midshaft bone
from the study groups and observed signiﬁcant differences
between Shn3–/– and WT at all studied ages. The OLS porosity
was higher, mainly because of a larger mean OLS area in the
Shn3–/–mice. Apart from these differences in genotype, we also
observed changes in OLS characteristics as a result of age. Corti-
cal bone from younger animals showed larger OLS porosity and
OLS area than that from older animals. This may be explained by
the presence of remnants of primary bone in the cortex of
younger mice. These remnants of primary bone have different
OLS morphology (Fig. 1, inset with detail); however, they dimin-
ish during the modeling process of the femur in the WT. In con-
trast, in a Shn3-deﬁciency, we found such remnants of primary
bone in the full-grown animals as well. This is likely caused by
the altered modeling, and is in line with the previous report of
decreased osteoclast activity in Shn3-deﬁciency.(4) However,
the differences in OLS characteristics are not exclusively caused
by the presence or absence of such primary bone remnants.
We have compared OLS characteristics separately in cortical
lamellar bone between the genotypes (data not shown) and
found similarly increased OLS porosity, OLS area, and OLS perim-
eter in Shn3-deﬁcient bone in line with the results obtained from
the entire cortex. The reason for differences in the morphology
of the osteocyte lacunae remains unknown as no information
on osteocyte activity or viability in Shn3-deﬁciency is available.
Apart from the mineral, the second essential component of
the bone material is its organic constituent, mainly type I colla-
gen. Its most distinct feature in mineralized tissues is its cross-
linking chemistry, providing the ﬁbrillar matrices with various
mechanical properties.(17) Cross-link type and relative amounts
depend on tissue age, bone turnover, and environmental fac-
tors.(33) Studies suggest that altered collagen cross-links contrib-
ute to changes of bonemechanical performance independent of
proper bone mineralization.(24,34–36) Furthermore, in patients
Table 4. Osteocyte Lacunae Sections (OLS) Characteristics of Cortical Bone of the Femur




(n = 8 )
Shn3–/













OLS-porosity (% ) 1.4 1.7 c 0.9 e 1.2 c, e 0.7 d 0.9 d ns <.001 <.001
(0.4) (0.4) (0.1) (0.1) (0.1) (0.1)
OLS-density (nb./mm2) 603 629 467 d 519 e 474 d 509 e ns ns <.001
(112) (79) (25) (16) (45) (29)
OLS-area (μm2) 23.8 27.7a 19.5 e 23.9 b, e 15.6 d, g 18.8 b, d, f ns <.001 <.001
(2.3) (3.6) (0.9) (1.4) (2.1) (1.8)
OLS-perimeter (μm) 21.3 22.1 19.5 e 21.0 b 17.6 d, g 19.0 b, d, g ns <.001 <.001
(0.8) (1.5) (0.3) (0.8) (1.2) (1.0)
Data are mean (SD). n = number of studied mice. In bold: data that are signiﬁcantly different to WT at similar age (based on post hoc comparison). Sig-
niﬁcance by Tukey post hoc comparison following two-way ANOVA is indicated by superscript letters.
ap = .001.
bp < .01.




gp < .01 18 months versus 4 months (all based on post hoc comparison).
Table 5. Collagen Cross-Link Ratios of Cancellous Bone
6 Weeks 4 Months Two-way ANOVA (p values)
WT (n = 7) Shn3–/– (n = 7) WT (n = 4) Shn3–/– (n = 6) Inter action geno type Age
Pyr/divalent 0.34 0.32 0.34 0.41 .493 .362 .119
(0.09) (0.09) (0.23) (0.09)
Data are mean (SD). n = number of studied samples.
Pyr/divalent = collagen cross-link ratio index (trivalent pyridinoline cross-links divided by divalent ones).
JBMR® Plus BONE PROPERTIES IN SHN3-NULL MICE 9 of 11 n
with idiopathic osteoporosis, increased bone fragility was found
associated with a higher collagen cross-links ratio.(37) In this con-
text, the similarity of collagen cross-linking in the Shn3-null and
WT mice is an essential ﬁnding for the mechanical properties of
the bone material.
We conclude that the bone volume under Shn3–/– deﬁciency
is highly increased and both femora and vertebrae have higher
ultimate force in mechanical testing. Taking the geometry of
the femora and vertebrae into account, the estimated apparent
strength of Shn3–/– bone remains higher than that of WT mice,
suggesting no deterioration of the bone material properties in
Shn3-deﬁciency. No indications for changes in themineralization
kinetics are observed. The increased degree of bone matrix min-
eralization is likely caused by a larger bone volume/area in the
Shn3-deﬁcient mice, a hypothesis that is conﬁrmed by computer
modeling. If one succeeds in regulating the excessive increase in
bone volume, the inhibition of Shn3 expression or activity might
be a promising target for the development of antiosteoporotic
drugs.
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